相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma
Stefan Wilop et al.
EPIGENETICS (2011)
Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma
Kota Iwahori et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Epigenetic Silencing of SOCS3 Identifies a Subset of Prostate Cancer With an Aggressive Behavior
Francesco Pierconti et al.
PROSTATE (2011)
Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma
Fanny Baran-Marszak et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Molecular biology of mantle cell lymphoma: From profiling studies to new therapeutic strategies
Antonia Obrador-Hevia et al.
BLOOD REVIEWS (2009)
Restoration of SOCS3 suppresses human lung adenocarcinoma cell growth by downregulating activation of Erk1/2, Akt apart from STAT3
Zu-bin Yu et al.
CELL BIOLOGY INTERNATIONAL (2009)
Epigenetic Alterations in Cholangiocarcinoma-Sustained IL-6/STAT3 Signaling in Cholangiocarcinoma due to SOCS3 Epigenetic Silencing
Hajime Isomoto
DIGESTION (2009)
Suppressor of cytokine signalling-3 inhibits tumor necrosis factor-alpha induced apoptosis and signalling in beta cells
Christine Bruun et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism
P. Gelebart et al.
LEUKEMIA (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
STAT3 as a target for inducing apoptosis in solid and hematological tumors
Khandaker Al Zaid Siddiquee et al.
CELL RESEARCH (2008)
Mantle cell lymphoma: advances in biology and therapy
Mitchell R. Smith
CURRENT OPINION IN HEMATOLOGY (2008)
Therapeutic options in mantle cell lymphoma
Saar Gill et al.
LEUKEMIA & LYMPHOMA (2008)
Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway
Jeong-Ho Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics
Pedro Jares et al.
NATURE REVIEWS CANCER (2007)
Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon
R. J. Rigby et al.
ONCOGENE (2007)
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Cinta Mestre-Escorihuela et al.
BLOOD (2007)
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Martina Rudelius et al.
BLOOD (2006)
Molecular cross-talk between the NFκB and STAT3 signaling pathways in head and neck squamous cell carcinoma
Cristiane H. Squarize et al.
NEOPLASIA (2006)
Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis
Hisanobu Ogata et al.
GASTROENTEROLOGY (2006)
JAW/STAT signal transduction: Regulators and implication in hematological malignancies
L Valentino et al.
BIOCHEMICAL PHARMACOLOGY (2006)
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition
A Weber et al.
ONCOGENE (2005)
Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
S Shishodia et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Genome-wide array-based CGH for mantle cell lymphoma:: identification of homozygous deletions of the proapoptotic gene BIM
H Tagawa et al.
ONCOGENE (2005)
Are SOCS suppressors, regulators, and degraders?
JA Johnston
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Altered apoptosis pathways in mantle cell lymphoma
M Rummel et al.
LEUKEMIA & LYMPHOMA (2004)
Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1β-mediated toxicity through inhibition of multiple nuclear factor-κB-regulated proapoptotic pathways
AE Karlsen et al.
DIABETOLOGIA (2004)
Differential hypermethylation of SOCS genes in ovarian and breast carcinomas
KD Sutherland et al.
ONCOGENE (2004)
Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line
KF To et al.
BRITISH JOURNAL OF CANCER (2004)
Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3
KJ Peltola et al.
BLOOD (2004)
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
B He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inhibition of constitutive NF-κB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis
LV Pham et al.
JOURNAL OF IMMUNOLOGY (2003)
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma
O Galm et al.
BLOOD (2003)
Regulatory effect of SOCS on NF-κB activity in murine monocytes/macrophages
SH Park et al.
DNA AND CELL BIOLOGY (2003)
Suppressors of cytokine signaling and immunity
M Kubo et al.
NATURE IMMUNOLOGY (2003)
Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours
R Lai et al.
JOURNAL OF PATHOLOGY (2003)
SOCS proteins: Negative regulators of cytokine signaling
DL Krebs et al.
STEM CELLS (2001)
分享论文
